MERCK - The Impact of Applying AI from Site Identification through Enrollment

Session details:

The clinical trials landscape is becoming more saturated, leading to delays and growing execution risks across late-phase clinical study portfolios. Merck presents on how they are implementing Artificial Intelligence to bring efficiencies to its operations team and clinical trial sites. Key Takeaways: 

• Merck’s approach to solving the age-old site-failure problem 
• How AI can enhance existing processes around site and patient identification 
• Early case analysis on the application of AI technology to site and patient identification